ArticleScientific reports2026
RCAF for patient-level thyroid ultrasound malignancy prediction under leakage-free evaluation and calibration.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate differentiation between benign and malignant thyroid nodules on ultrasound remains clinically important, yet interpretation is operator-dependent and subject to inter-observer variability. Recent deep learning studies report strong performance for thyroid ultrasound classification, but many prior approaches remain centred on image-level prediction, with limited emphasis on patient-level baselines, calibration-aware evaluation, and mask-related shortcut analysis. To address these gaps, we present a patient-level thyroid ultrasound malignancy prediction framework centred on a Region-Aware Context-Aware Fusion (RCAF) model evaluated under a strict leakage-free protocol. RCAF combines lesion-focused and context-preserving frame representations through a dual-branch design with gated fusion, followed by attention-based multiple instance learning (AttnMIL) for patient-level aggregation. The framework incorporates development-only probability calibration and threshold selection before single-shot evaluation on an untouched independent test cohort. Experiments on the public ThyroidXL benchmark show that RCAF outperforms stronger fair patient-level baselines, including image-only, transformer-based, and lesion-only comparators. Calibration analysis improves probability reliability, threshold analysis demonstrates stable behaviour under clinically relevant operating conditions, and shortcut sensitivity experiments show that naive mask concatenation produces shortcut-prone gains, whereas RCAF degrades by only 0.001 ROC-AUC under within-patient mask permutation, supporting principled region-aware reasoning. For cross-domain assessment, RCAF was evaluated on TN5000, a Chinese thyroid ultrasound dataset acquired under different imaging conditions; following domain adaptation and 8-view test-time augmentation, the model achieved AUC = 0.914 [0.879-0.948] on a class-balanced validation subset. Overall, RCAF constitutes a strong patient-level thyroid ultrasound classification framework, with encouraging cross-domain adaptability. Broader prospective multi-centre validation remains necessary before clinical deployment.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.